Nephrology Research

A study of the Efficacy and Safety of Sparsentan for the treatment of Immunoglobulin A Nephropathy.

Survival Improvement with Colecalciferol in patients on dialysis.

This study is testing whether a new drug, BI 690517, can help protect kidney and heart health when taken with empagliflozin.

This study is testing whether lowering phosphate levels in dialysis patients helps them live longer, feel better, and have healthier hearts.

This study is testing a new treatment in adults with chronic kidney disease and high blood pressure, all already on standard medication.

This study is testing different doses of a new drug (CSL300) to find the safest and most effective one for people on dialysis with heart disease or diabetes.

This study will test if giving regular vitamin D (cholecalciferol) to dialysis patients helps them live longer and avoid heart disease, infections and cancer.